Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,774 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive value of post-treatment C-reactive protein-to-albumin ratio in locally advanced non-small cell lung cancer patients receiving durvalumab after chemoradiotherapy.
Araki T, Tateishi K, Komatsu M, Sonehara K, Wasamoto S, Koyama S, Yoshiike F, Hama M, Nishie K, Kondo D, Agatsuma T, Kato A, Takata M, Kanda S, Hanaoka M, Koizumi T. Araki T, et al. Among authors: komatsu m. Thorac Cancer. 2022 Jul;13(14):2031-2040. doi: 10.1111/1759-7714.14484. Epub 2022 May 26. Thorac Cancer. 2022. PMID: 35616056 Free PMC article.
Comparison of the chemokine profiles in the bronchoalveolar lavage fluid between IgG4-related respiratory disease and sarcoidosis: CC-chemokine ligand 1 might be involved in the pathogenesis of sarcoidosis.
Yamamoto H, Yasuo M, Komatsu M, Ushiki A, Hamano H, Hori A, Nakajima T, Uehara T, Fujinaga Y, Matsui S, Hanaoka M. Yamamoto H, et al. Among authors: komatsu m. Cytokine. 2019 Aug;120:125-129. doi: 10.1016/j.cyto.2019.04.017. Epub 2019 May 4. Cytokine. 2019. PMID: 31063909
The efficacy of amrubicin third-line chemotherapy in patients with relapsed extensive-disease small-cell lung cancer: A retrospective and historical study in a single institute.
Sonehara K, Tateishi K, Fukushima T, Komatsu M, Yamamoto H, Koizumi T, Hanaoka M. Sonehara K, et al. Among authors: komatsu m. Thorac Cancer. 2019 Sep;10(9):1805-1811. doi: 10.1111/1759-7714.13150. Epub 2019 Jul 27. Thorac Cancer. 2019. PMID: 31350820 Free PMC article. Clinical Trial.
A comparison of the features of fluorine-18 fluorodeoxyglucose-positron emission tomography (FDG-PET) between IgG4-related disease with bilateral hilar lymphadenopathy and sarcoidosis.
Ozawa Y, Yamamoto H, Yasuo M, Komatsu M, Ushiki A, Hamano H, Uehara T, Kawakami S, Fujita A, Fujinaga Y, Oguchi K, Kawa S, Hanaoka M. Ozawa Y, et al. Among authors: komatsu m. Nagoya J Med Sci. 2020 Feb;82(1):101-111. doi: 10.18999/nagjms.82.1.101. Nagoya J Med Sci. 2020. PMID: 32273638 Free PMC article.
1,774 results